1.98
Schlusskurs vom Vortag:
$1.92
Offen:
$1.96
24-Stunden-Volumen:
7,041
Relative Volume:
0.24
Marktkapitalisierung:
$71.76M
Einnahmen:
$24.38M
Nettoeinkommen (Verlust:
$-53.95M
KGV:
-0.8016
EPS:
-2.47
Netto-Cashflow:
$-23.31M
1W Leistung:
-7.04%
1M Leistung:
-5.71%
6M Leistung:
-34.22%
1J Leistung:
-47.62%
Elutia Inc Stock (ELUT) Company Profile
Firmenname
Elutia Inc
Sektor
Branche
Telefon
240-247-1143
Adresse
12510 PROSPERITY DRIVE, SILVER SPRING
Vergleichen Sie ELUT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ELUT
Elutia Inc
|
1.95 | 78.94M | 24.38M | -53.95M | -23.31M | -2.47 |
![]()
ABT
Abbott Laboratories
|
126.17 | 220.16B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
106.47 | 157.03B | 18.49B | 2.51B | 2.72B | 1.68 |
![]()
SYK
Stryker Corp
|
401.69 | 154.21B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
92.56 | 119.08B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
79.36 | 46.93B | 5.69B | 4.15B | 623.10M | 6.95 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2020-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
2020-11-02 | Eingeleitet | Cowen | Outperform |
2020-11-02 | Eingeleitet | Piper Sandler | Overweight |
2020-11-02 | Eingeleitet | Truist | Buy |
Elutia Inc Aktie (ELUT) Neueste Nachrichten
Is it the right time to buy Elutia Inc. stockReal Time Signals For Consistent Profits - jammulinksnews.com
What makes Elutia Inc. stock price move sharply Free Community Entry Consensus Trade Ideas - Newser
What makes Elutia Inc. stock price move sharply Free Daily Momentum Screener With Alerts - Newser
Will Elutia Inc. continue its uptrend Free Trend Following Strategy With Stop Loss - Newser
Why is Elutia Inc. stock attracting strong analyst attentionInvest smarter with daily trading signals - jammulinksnews.com
How does Elutia Inc. compare to its industry peersUncover the best stocks for explosive growth - jammulinksnews.com
What institutional investors are buying Elutia Inc. stockUnlock powerful stock screening tools - jammulinksnews.com
Will Elutia Inc. Stock Benefit from AI and Green Energy TrendsFree Stock Selection with 300% Return - Newser
What are the latest earnings results for Elutia Inc.Build a balanced portfolio for long-term success - jammulinksnews.com
How Elutia Inc. stock performs during market volatilityMarket Beating Strategy - Newser
What analysts say about Elutia Inc. stockSuperior profit margins - PrintWeekIndia
Is Elutia Inc. a good long term investmentFree Investment Community - PrintWeekIndia
Elutia Inc. Stock Analysis and ForecastOutperformance with explosive growth - Autocar Professional
What drives Elutia Inc. stock priceHigh-performance investment picks - jammulinksnews.com
KAPA Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com
Is TENB a good long term investmentHigh-yield investments - jammulinksnews.com
What makes Elutia Inc. stock price move sharplyRisk Controlled Trading Ideas - Newser
WEAV Stock Analysis and ForecastPowerful growth strategies - jammulinksnews.com
[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Yahoo Finance
MSPRW Stock Analysis and ForecastExceptional market positioning - Jammu Links News
What analysts say about FatPipe Inc. stockGame-changing returns - jammulinksnews.com
What drives Middlesex Water Company stock priceSkyrocketing profit margins - jammulinksnews.com
Best Growth Stocks Stock Market Research ExpertsSkyrocketing investment returns - jammulinksnews.com
What analysts say about AnaptysBio Inc. stockMassive wealth growth - jammulinksnews.com
Why Elutia Inc. stock attracts strong analyst attentionQuick Profit Idea Stream - Newser
Elutia (NASDAQ:ELUT) Trading Down 2.5% – Here’s What Happened - Defense World
Elutia Inc. Announces Promising Study Results for EluPro BioEnvelope in Improving Healing Outcomes for Cardiac Implantable Electronic Devices - Nasdaq
Clinical Study: Revolutionary Antibiotic Technology Shows Superior Results for Heart Implants - Stock Titan
Elutia announces publication of new study on CIED biologic envelope - TipRanks
Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards - GlobeNewswire
Finanzdaten der Elutia Inc-Aktie (ELUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Elutia Inc-Aktie (ELUT) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
HighCape Capital, L.P. | Director |
Feb 03 '25 |
Buy |
2.50 |
420,000 |
1,050,000 |
9,520,232 |
Ferguson Matthew | CHIEF FINANCIAL OFFICER |
Jul 31 '24 |
Option Exercise |
1.43 |
105,080 |
150,002 |
257,823 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):